Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects

Chinese Journal of Integrative Medicine

Volumn 15, Issue 1, 2009, Pages 34-41

  He, Rong Rong ^a   Chen, Ling ^b   Lin, Bing Hui ^b   Matsui, Yokichi ^c   Yao, Xin Sheng ^a,d   Kurihara, Hiroshi ^d  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Fujian Institute of Traditional Chinese Medicine   (China)

^c SUNTORY LTD   (Japan)

^d JINAN UNIVERSITY   (China)

Author keywords

Cholesterol; Obesity; Oolong tea; Overweight; Pancreatic lipase; Triglycerine

Indexed keywords

ANTIOBESITY AGENT; CATECHIN GALLATE; CHOLESTEROL; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GALLOCATECHIN GALLATE; LIPOPROTEIN; OOLONG TEA EXTRACT; PLANT EXTRACT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AGED; ARTICLE; BODY FAT; BODY HEIGHT; BODY WEIGHT; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OBESITY; OOLONG TEA; PRIORITY JOURNAL; TEA; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; ANIMALS; BEVERAGES; BODY HEIGHT; BODY WEIGHT; CATECHIN; CHOLESTEROL; DIET; FEEDING BEHAVIOR; FEMALE; HUMANS; LIPASE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PHYTOTHERAPY; PLANT EXTRACTS; SUBCUTANEOUS FAT; SUS SCROFA; TEA; TRIGLYCERIDES; YOUNG ADULT;

EID: 60849090472     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-009-0034-8     Document Type: Article

References (39)

1. Abelson P, Kennedy D. The obesity epidemic. Science 2004;304:1413.
2. Hill JO, Melanson EL, Wyatt HT. Dietary fat intake and regulation of energy balance: Implications for obesity. J Nutr 2000; 130: 284S-288S.
3. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882-889.
4. Astrup A, Buemann B, Western P, Toubro S, Raben A, Christensen NJ. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutri 1994;59:350-355.
5. Campfield LA, Smith FJ, Burn P. Strategies and potential molecular targets for obesity treatment. Science 1998; 280:1383-1387.
6. Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805-875.
7. Han LK, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea. Int J Obes 1999;23:98-105.
8. Kuo KL, Weng MS, Chiang CT, Tsai YJ, Lin-Shiau SY, Lin JK. Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J Agric Food Chem 2005; 53:489-489.
9. Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, et al. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001;131:2848-2852.
10. Okuda H, Han LK. Medicinal plant and its related metabolic modulators. Nippon Yakurigaku Zasshi 2001;118:347-351.
11. Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 2003;133:3298-3302.
12. Khosla T, Lowe CR. Indices of obesity derived from body weight and height. Br J Prev Soc Med 1967;21:122-128.
13. WHO Physical Status: The use and interpretation of anthropometry. Report of a WHO expert committee Geneva: World Health Organization Technical Report Seriels; 1995:854.
14. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on obesity, Geneva 3-5, June 1997. World Health Organization Techinical Report Series. Vol. 210. Geneva: World Health Organization;1997:1-276.
15. Xie B, Shi H, Chen Q, Ho CT. Antioxidant properties of fractions and polyphenol constituents from green, oolong and black teas. Proc Natl Sci Counc Repub China (B) 1993;17:77-84.
16. Bitou N, Ninomiya M, Tsujita T, Okuda H. Screening of lipase inhibitors from marine algae. Lipids 1999;34:441-445.
17. Golor G, Yamashita K, Koner W, Hagenmaier H, Neubert D. Kinetics and inductive potency of 1, 2, 3, 4, 6, 7, 8-heptachlorodibenzo-p-dioxin (H7CDD) in rats. Life Sci 2001;69:493-508.
18. Saris W. Sugars, energy metabolism, and body weight control. Am J Clini Nutri 2003;78:850-857.
19. Iwata K, Inayama T, Miw S, Kawaguchi K, Koike G. Effect of oolong tea on plasma lipids and lipoprotein lipase activity in young women. J Jpn Soc Nutr Food Sci 1991;44:251-259.
20. Lin YS, Tsai YJ, Tsay JS, Lin JK. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 2003;51:1864-1873.
21. Dulloo AG, Dure C, Rohrer D, Girardier L, Mensi N, Fathi M. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutri 1999;70:1040-1045.
22. Bianchi CP. Cellular pharmacology of contraction of skeletal muscle. In: Narahashi T, ed. Cellular pharmacology of excitable tissues. Charles C: Thomas Publisher;1975:485-519.
23. Arciero PJ, Gardner AW, Calles-Escandon J, Benowitz NL, Poehlman ET. Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol 1995;268:E1192-E1198.
24. Couturier C, Janvier B, Girlich D, Bereziat G, Andreani-Mangeney M. Effects of caffeine on lipoprotein lipase gene expression during the adipocyte differentiation process. Lipids 1998;33:455-460.
25. Mulder H, Hoist LS, Svensson H, Degerman E, Sundler F, Ahren B. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes 1999;48: 228-232.
26. Kao YH, Hiipakka RA, Liao S. Modulation of obesity by green tea catechins. Am J Clin Nutr 2000;72:1232-1233.
27. Watanabe J, Kawabata J, Niki R. Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Biosci Biotechnol Biochem 1998;62:532-534.
28. Nakahara K, Izumi R, Kodama T, Kiso Y, Tanaka T. Inhibition of postprandial hyperglycaemia by oolong tea extract (OTE). Phytother Res 1994;8:433-435.
29. Han LK, Kimura Y, Kawashima M, Takaku T, Taniyama T, Hayashi T, et al. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int J Obes 2001;25:1459-1464.
30. Inui Y, Kawata S, Matsuzawa Y, Tokunaga K, Fujioka A, Tamura S, et al. Increased level of apolipoprotein B mRNA in the liver of ventromedial hypothalamus lesioned obese rats. Biochim Biophys Res Commun 1989;163:1107-1112.
31. Wang SR, Infante J, Catala D, Petit D, Bonnefis MT, Infante R. Lipid and lipoprotein synthesis in isolated and cultured hepatocytes from lean and obese Zucker rats. Biochim Acta 1989;1002:302-311.
32. Garrison RJ, Wilson PW, Castelli WP, Feinleib M, Kannel WB, McNamara PM. Obesity and lipoprotein cholesterol in the Framingham offspring study. Metabolism 1980;29:1053-1060.
33. Chisaka T, Matsuda H, Kubomura Y, Mochizuki M, Yamahara J, Fujimura H. The effect of crude drugs on experimental hypercholesteremia: Mode of action of (-)-epigallocatechin gallate in tea leaves. Chem Pharm Bull 1988;36:227-233.
34. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao T, Takeo T, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992;1127:141-146.
35. Okuda T, Kimura Y, Yoshida T, Hatano T, Okuda H, Arichi S. Studies on the activities of tannins and related compounds from medicinal plants and drugs. I. Inhibitory effects on lipid peroxdation in mitochondria and microsomes of liver. Chem Pharm Bull 1983;31:1625-1631.
36. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 1986;32:613-622.
37. Matsuda H, Chisaka T, Kubomura Y, Yamahara J, Sawada T, Fujimura H. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharmacol 1986;17:213-224.
38. Hasegawa N, Yamda N, Mori M. Powdered green tea has antilipogenic effect on Zucker rats fed a high-fat diet. Phytother Res 2003;17:477-480.
39. Matsuzawa Y. Life style-related disease. Nippon Rinsho 2001;59:188-194.